Fingerprint
Dive into the research topics of 'Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)
Elizabeth Dudnik*, Elias Bshara, Ahuva Grubstein, Ludmila Fridel, Tzippy Shochat, Laila C. Roisman, Maya Ilouze, Anna Belilovski Rozenblum, Smadar Geva, Alona Zer, Ofer Rotem, Aaron M. Allen, Nir Peled
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
57
Scopus
citations